Rank | Gene Set | Z-score |
---|---|---|
1 | lysine catabolic process (GO:0006554) | 5.66974478 |
2 | lysine metabolic process (GO:0006553) | 5.66974478 |
3 | L-phenylalanine catabolic process (GO:0006559) | 5.53344225 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53344225 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.41343695 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.41343695 |
7 | * fatty acid beta-oxidation (GO:0006635) | 5.08808411 |
8 | fatty acid transmembrane transport (GO:1902001) | 5.08493327 |
9 | carnitine shuttle (GO:0006853) | 5.06266673 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.96702216 |
11 | glyoxylate metabolic process (GO:0046487) | 4.95548691 |
12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87182583 |
13 | aromatic amino acid family catabolic process (GO:0009074) | 4.82310579 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81769996 |
15 | tricarboxylic acid cycle (GO:0006099) | 4.78551672 |
16 | regulation of triglyceride catabolic process (GO:0010896) | 4.74418091 |
17 | 2-oxoglutarate metabolic process (GO:0006103) | 4.73115356 |
18 | regulation of sequestering of triglyceride (GO:0010889) | 4.65558735 |
19 | amino-acid betaine metabolic process (GO:0006577) | 4.65325957 |
20 | acetyl-CoA metabolic process (GO:0006084) | 4.64881817 |
21 | * fatty acid oxidation (GO:0019395) | 4.63189817 |
22 | kynurenine metabolic process (GO:0070189) | 4.61938741 |
23 | cellular ketone body metabolic process (GO:0046950) | 4.58762621 |
24 | * fatty acid catabolic process (GO:0009062) | 4.56621163 |
25 | * lipid oxidation (GO:0034440) | 4.55114388 |
26 | aspartate family amino acid catabolic process (GO:0009068) | 4.51352448 |
27 | short-chain fatty acid metabolic process (GO:0046459) | 4.42108921 |
28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.29738095 |
29 | bile acid biosynthetic process (GO:0006699) | 4.29087460 |
30 | carnitine metabolic process (GO:0009437) | 4.27587241 |
31 | branched-chain amino acid catabolic process (GO:0009083) | 4.25373480 |
32 | indole-containing compound catabolic process (GO:0042436) | 4.24129131 |
33 | indolalkylamine catabolic process (GO:0046218) | 4.24129131 |
34 | tryptophan catabolic process (GO:0006569) | 4.24129131 |
35 | sulfur amino acid catabolic process (GO:0000098) | 4.22507891 |
36 | * monocarboxylic acid catabolic process (GO:0072329) | 4.20865563 |
37 | cysteine metabolic process (GO:0006534) | 4.18705138 |
38 | valine metabolic process (GO:0006573) | 4.17752063 |
39 | biotin metabolic process (GO:0006768) | 4.14158511 |
40 | positive regulation of fatty acid oxidation (GO:0046321) | 4.05088907 |
41 | tryptophan metabolic process (GO:0006568) | 4.01960878 |
42 | urea cycle (GO:0000050) | 3.99819461 |
43 | urea metabolic process (GO:0019627) | 3.99819461 |
44 | carnitine transmembrane transport (GO:1902603) | 3.99603964 |
45 | NADH metabolic process (GO:0006734) | 3.96726301 |
46 | ketone body metabolic process (GO:1902224) | 3.95303109 |
47 | branched-chain amino acid metabolic process (GO:0009081) | 3.94599251 |
48 | mannose metabolic process (GO:0006013) | 3.91183121 |
49 | carnitine transport (GO:0015879) | 3.90645068 |
50 | amino-acid betaine transport (GO:0015838) | 3.90645068 |
51 | serine family amino acid catabolic process (GO:0009071) | 3.87417845 |
52 | negative regulation of fibrinolysis (GO:0051918) | 3.86285991 |
53 | alpha-amino acid catabolic process (GO:1901606) | 3.85239813 |
54 | ethanol oxidation (GO:0006069) | 3.84698714 |
55 | homocysteine metabolic process (GO:0050667) | 3.83807082 |
56 | complement activation, alternative pathway (GO:0006957) | 3.83657118 |
57 | acylglycerol homeostasis (GO:0055090) | 3.83467642 |
58 | triglyceride homeostasis (GO:0070328) | 3.83467642 |
59 | * regulation of fatty acid oxidation (GO:0046320) | 3.80572285 |
60 | tricarboxylic acid metabolic process (GO:0072350) | 3.79961695 |
61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.78489698 |
62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76646094 |
63 | protein carboxylation (GO:0018214) | 3.76646094 |
64 | positive regulation of lipid catabolic process (GO:0050996) | 3.73960467 |
65 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.73944224 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 3.72372521 |
67 | nitrogen cycle metabolic process (GO:0071941) | 3.72050047 |
68 | regulation of protein activation cascade (GO:2000257) | 3.69941366 |
69 | * organic acid catabolic process (GO:0016054) | 3.69754220 |
70 | * carboxylic acid catabolic process (GO:0046395) | 3.69754220 |
71 | cellular amino acid catabolic process (GO:0009063) | 3.67159511 |
72 | regulation of fibrinolysis (GO:0051917) | 3.65937084 |
73 | succinate metabolic process (GO:0006105) | 3.65685897 |
74 | bile acid metabolic process (GO:0008206) | 3.62260333 |
75 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.61518558 |
76 | phospholipid homeostasis (GO:0055091) | 3.57434344 |
77 | coenzyme catabolic process (GO:0009109) | 3.54549291 |
78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54028493 |
79 | oxaloacetate metabolic process (GO:0006107) | 3.50522143 |
80 | aromatic amino acid family metabolic process (GO:0009072) | 3.50230678 |
81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49585685 |
82 | regulation of complement activation (GO:0030449) | 3.47910193 |
83 | protein-lipid complex remodeling (GO:0034368) | 3.41324196 |
84 | macromolecular complex remodeling (GO:0034367) | 3.41324196 |
85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.41324196 |
86 | low-density lipoprotein particle clearance (GO:0034383) | 3.38811401 |
87 | reverse cholesterol transport (GO:0043691) | 3.38750985 |
88 | regulation of cholesterol esterification (GO:0010872) | 3.37446824 |
89 | tyrosine metabolic process (GO:0006570) | 3.36393462 |
90 | creatine metabolic process (GO:0006600) | 3.35815994 |
91 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.34155494 |
92 | thioester metabolic process (GO:0035383) | 3.33540321 |
93 | acyl-CoA metabolic process (GO:0006637) | 3.33540321 |
94 | glutamate metabolic process (GO:0006536) | 3.30810823 |
95 | cellular modified amino acid catabolic process (GO:0042219) | 3.29237342 |
96 | quaternary ammonium group transport (GO:0015697) | 3.27499400 |
97 | acyl-CoA biosynthetic process (GO:0071616) | 3.27328907 |
98 | thioester biosynthetic process (GO:0035384) | 3.27328907 |
99 | negative regulation of lipase activity (GO:0060192) | 3.26482815 |
100 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.23973891 |
101 | phospholipid efflux (GO:0033700) | 3.19935434 |
102 | actin-myosin filament sliding (GO:0033275) | 3.18993713 |
103 | muscle filament sliding (GO:0030049) | 3.18993713 |
104 | Golgi transport vesicle coating (GO:0048200) | 3.17604610 |
105 | COPI coating of Golgi vesicle (GO:0048205) | 3.17604610 |
106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13041374 |
107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13041374 |
108 | fatty acid homeostasis (GO:0055089) | 3.12995152 |
109 | cellular glucuronidation (GO:0052695) | 3.12206006 |
110 | negative regulation of cholesterol transport (GO:0032375) | 3.10829179 |
111 | regulation of cholesterol homeostasis (GO:2000188) | 2.99824650 |
112 | barbed-end actin filament capping (GO:0051016) | 2.93580079 |
113 | pinocytosis (GO:0006907) | 2.81671045 |
114 | protein retention in ER lumen (GO:0006621) | 2.76222542 |
115 | negative regulation of cell size (GO:0045792) | 2.75277625 |
116 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75187313 |
117 | regulation of cholesterol storage (GO:0010885) | 2.74787798 |
118 | fructose metabolic process (GO:0006000) | 2.67022537 |
119 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.64236831 |
120 | diacylglycerol metabolic process (GO:0046339) | 2.60741018 |
121 | angiotensin maturation (GO:0002003) | 2.57766520 |
122 | focal adhesion assembly (GO:0048041) | 2.57389295 |
123 | cell-substrate adherens junction assembly (GO:0007045) | 2.57389295 |
124 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.57060431 |
125 | basement membrane organization (GO:0071711) | 2.56308752 |
126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56065426 |
127 | glycosphingolipid catabolic process (GO:0046479) | 2.55932418 |
128 | cardiac muscle contraction (GO:0060048) | 2.55894608 |
129 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.54312780 |
130 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.52719302 |
131 | actin-mediated cell contraction (GO:0070252) | 2.52553240 |
132 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51716009 |
133 | response to mercury ion (GO:0046689) | 2.51599760 |
134 | negative regulation of fatty acid transport (GO:2000192) | 2.51015654 |
135 | desmosome organization (GO:0002934) | 2.50573884 |
136 | regulation of necrotic cell death (GO:0010939) | 2.48918403 |
137 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48609763 |
138 | cell-substrate junction assembly (GO:0007044) | 2.46747621 |
139 | adhesion of symbiont to host (GO:0044406) | 2.46137344 |
140 | positive regulation of extracellular matrix organization (GO:1903055) | 2.45173129 |
141 | regulation of apoptotic cell clearance (GO:2000425) | 2.44914499 |
142 | protein-lipid complex assembly (GO:0065005) | 2.44102296 |
143 | epoxygenase P450 pathway (GO:0019373) | 2.43551290 |
144 | adherens junction assembly (GO:0034333) | 2.41818216 |
145 | negative regulation of necroptotic process (GO:0060546) | 2.40742248 |
146 | sarcomere organization (GO:0045214) | 2.38523795 |
147 | skeletal muscle adaptation (GO:0043501) | 2.37376174 |
148 | glycolipid catabolic process (GO:0019377) | 2.36938362 |
149 | cell volume homeostasis (GO:0006884) | 2.35544468 |
150 | stress fiber assembly (GO:0043149) | 2.35456564 |
151 | regulation of skeletal muscle contraction (GO:0014819) | 2.34997561 |
152 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.34232603 |
153 | epithelial cell-cell adhesion (GO:0090136) | 2.33793466 |
154 | actin filament depolymerization (GO:0030042) | 2.32850818 |
155 | gluconeogenesis (GO:0006094) | 2.32311978 |
156 | complement activation, classical pathway (GO:0006958) | 2.32053709 |
157 | triglyceride catabolic process (GO:0019433) | 2.30941578 |
158 | regulation of necroptotic process (GO:0060544) | 2.30780064 |
159 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.30065442 |
160 | negative regulation of lipid transport (GO:0032369) | 2.28926911 |
161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.27765742 |
162 | acylglycerol catabolic process (GO:0046464) | 2.27427813 |
163 | neutral lipid catabolic process (GO:0046461) | 2.27427813 |
164 | * regulation of fatty acid biosynthetic process (GO:0042304) | 2.27292520 |
165 | protein localization to endosome (GO:0036010) | 2.27008849 |
166 | proline biosynthetic process (GO:0006561) | 2.24910940 |
167 | actin filament-based movement (GO:0030048) | 2.24669242 |
168 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.23854310 |
169 | response to thyroid hormone (GO:0097066) | 2.23753691 |
170 | apoptotic cell clearance (GO:0043277) | 2.23353014 |
171 | acute-phase response (GO:0006953) | 2.22632871 |
172 | renal filtration (GO:0097205) | 2.22092423 |
173 | GDP-mannose metabolic process (GO:0019673) | 2.20759800 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.70874399 |
2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.17074911 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.78809620 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.06302845 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.40399082 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.57833445 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.36445957 |
8 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.04977645 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.69490895 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.64856546 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.22846625 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.58006485 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52449569 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51619819 |
15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.33104164 |
16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25185785 |
17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13457789 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11860366 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06580718 |
20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95189036 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91743018 |
22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87182077 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85910643 |
24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80014213 |
25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76644829 |
26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75999143 |
27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75416184 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71811073 |
29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62725323 |
30 | P68_20966046_ChIP-Seq_HELA_Human | 1.61791746 |
31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58539008 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.57145779 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56469025 |
34 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54297958 |
35 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54297958 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52437089 |
37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50972716 |
38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49781258 |
39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49605520 |
40 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48462251 |
41 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48452036 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46589715 |
43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45954787 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43478936 |
45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41104038 |
46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40228165 |
47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39030562 |
48 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37583757 |
49 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37402172 |
50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37127927 |
51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36962772 |
52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35262697 |
53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34712211 |
54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31085546 |
55 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.27721946 |
56 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25917000 |
57 | MAF_26560356_Chip-Seq_TH1_Human | 1.23801545 |
58 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23154908 |
59 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22773430 |
60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22755097 |
61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22536571 |
62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20710341 |
63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19897038 |
64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19803791 |
65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18786537 |
66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17865515 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17587426 |
68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15705493 |
69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14592402 |
70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13354681 |
71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12565506 |
72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12503101 |
73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12370154 |
74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11807948 |
75 | MAF_26560356_Chip-Seq_TH2_Human | 1.10917426 |
76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10826998 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10041144 |
78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10004363 |
79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08532937 |
80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08522405 |
81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08234231 |
82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07472089 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07403945 |
84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07285662 |
85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06487449 |
86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06431752 |
87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05980650 |
88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05332580 |
89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04314913 |
90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02389889 |
91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01735992 |
92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01385273 |
93 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.01312570 |
94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01210137 |
95 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00791836 |
96 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99541456 |
97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98906175 |
98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94622936 |
99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94546374 |
100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87158109 |
101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86044402 |
102 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85147078 |
103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83424630 |
104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83071409 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82760716 |
106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81672226 |
107 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79100622 |
108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77939683 |
109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77939683 |
110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77044003 |
111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76569577 |
112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76211658 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75157890 |
114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74946339 |
115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73406018 |
116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72995566 |
117 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.72871371 |
118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71759197 |
119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.71277063 |
120 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71143632 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71046004 |
122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70206192 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68854543 |
124 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68317002 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68219133 |
126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67847945 |
127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64146900 |
128 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.63529027 |
129 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.62861791 |
130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62101944 |
131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60822157 |
132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60231291 |
133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60045709 |
134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59618452 |
135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59551519 |
136 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.59245509 |
137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58033415 |
138 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.57740093 |
139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57273591 |
140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.56873147 |
141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55627182 |
142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55001088 |
143 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54365363 |
144 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.53620175 |
145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53571629 |
146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53285668 |
147 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.53138662 |
148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.52946455 |
149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52131866 |
150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51973180 |
151 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51802975 |
152 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.51443406 |
153 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.51144384 |
154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51096698 |
155 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.50713152 |
156 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50338218 |
157 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.50140314 |
158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50073196 |
159 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49826375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.89283918 |
2 | MP0005360_urolithiasis | 5.55716601 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.75288036 |
4 | MP0005365_abnormal_bile_salt | 4.57835001 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 3.89758407 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55138569 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.49455330 |
8 | MP0005058_abnormal_lysosome_morphology | 3.16674622 |
9 | MP0010329_abnormal_lipoprotein_level | 3.00401777 |
10 | MP0003252_abnormal_bile_duct | 2.89918917 |
11 | MP0003646_muscle_fatigue | 2.85113361 |
12 | MP0004130_abnormal_muscle_cell | 2.71080736 |
13 | MP0009840_abnormal_foam_cell | 2.64305569 |
14 | MP0005670_abnormal_white_adipose | 2.61372703 |
15 | * MP0005332_abnormal_amino_acid | 2.53404565 |
16 | MP0003195_calcinosis | 2.45104022 |
17 | MP0004084_abnormal_cardiac_muscle | 2.26390310 |
18 | MP0005083_abnormal_biliary_tract | 2.14521014 |
19 | MP0000751_myopathy | 2.12077291 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.07825586 |
21 | * MP0002118_abnormal_lipid_homeostasis | 2.06372899 |
22 | * MP0005330_cardiomyopathy | 1.99252996 |
23 | MP0004215_abnormal_myocardial_fiber | 1.98187356 |
24 | MP0001666_abnormal_nutrient_absorption | 1.93297493 |
25 | MP0004036_abnormal_muscle_relaxation | 1.90329507 |
26 | * MP0006036_abnormal_mitochondrial_physio | 1.85033650 |
27 | * MP0000609_abnormal_liver_physiology | 1.83391448 |
28 | MP0004510_myositis | 1.79172632 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.79152567 |
30 | * MP0005666_abnormal_adipose_tissue | 1.74031609 |
31 | MP0000749_muscle_degeneration | 1.71138915 |
32 | MP0003566_abnormal_cell_adhesion | 1.69580837 |
33 | MP0004858_abnormal_nervous_system | 1.67671544 |
34 | MP0005409_darkened_coat_color | 1.64556404 |
35 | MP0003436_decreased_susceptibility_to | 1.56149891 |
36 | MP0008260_abnormal_autophagy | 1.54301351 |
37 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.53177197 |
38 | MP0004019_abnormal_vitamin_homeostasis | 1.47819169 |
39 | * MP0004087_abnormal_muscle_fiber | 1.47450557 |
40 | MP0001849_ear_inflammation | 1.47271982 |
41 | MP0004185_abnormal_adipocyte_glucose | 1.46949262 |
42 | MP0003300_gastrointestinal_ulcer | 1.46335162 |
43 | MP0003705_abnormal_hypodermis_morpholog | 1.46216380 |
44 | MP0003172_abnormal_lysosome_physiology | 1.46107016 |
45 | MP0008775_abnormal_heart_ventricle | 1.44436975 |
46 | * MP0002971_abnormal_brown_adipose | 1.43922206 |
47 | MP0002972_abnormal_cardiac_muscle | 1.42621588 |
48 | MP0001958_emphysema | 1.40445220 |
49 | MP0010234_abnormal_vibrissa_follicle | 1.40360672 |
50 | MP0009643_abnormal_urine_homeostasis | 1.40228906 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.40122437 |
52 | MP0005451_abnormal_body_composition | 1.38522788 |
53 | MP0005385_cardiovascular_system_phenoty | 1.37095809 |
54 | MP0001544_abnormal_cardiovascular_syste | 1.37095809 |
55 | MP0003279_aneurysm | 1.36764430 |
56 | MP0002269_muscular_atrophy | 1.32474549 |
57 | MP0002138_abnormal_hepatobiliary_system | 1.30962519 |
58 | MP0003303_peritoneal_inflammation | 1.29688909 |
59 | MP0005620_abnormal_muscle_contractility | 1.28475510 |
60 | MP0004947_skin_inflammation | 1.28290300 |
61 | MP0006138_congestive_heart_failure | 1.27200022 |
62 | MP0001764_abnormal_homeostasis | 1.25441411 |
63 | MP0003091_abnormal_cell_migration | 1.21981071 |
64 | MP0005023_abnormal_wound_healing | 1.17305061 |
65 | * MP0010630_abnormal_cardiac_muscle | 1.17246922 |
66 | MP0000858_altered_metastatic_potential | 1.16671607 |
67 | MP0003186_abnormal_redox_activity | 1.14917358 |
68 | MP0002877_abnormal_melanocyte_morpholog | 1.14408139 |
69 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14366732 |
70 | MP0000750_abnormal_muscle_regeneration | 1.13312824 |
71 | MP0005076_abnormal_cell_differentiation | 1.13132319 |
72 | MP0004233_abnormal_muscle_weight | 1.12387562 |
73 | * MP0000003_abnormal_adipose_tissue | 1.11498711 |
74 | MP0010368_abnormal_lymphatic_system | 1.09776823 |
75 | MP0006035_abnormal_mitochondrial_morpho | 1.09055326 |
76 | * MP0002078_abnormal_glucose_homeostasis | 1.08979767 |
77 | MP0003137_abnormal_impulse_conducting | 1.08927973 |
78 | * MP0005375_adipose_tissue_phenotype | 1.08026445 |
79 | MP0000747_muscle_weakness | 1.07207909 |
80 | * MP0005535_abnormal_body_temperature | 1.05264563 |
81 | MP0002796_impaired_skin_barrier | 1.04978811 |
82 | MP0003075_altered_response_to | 1.04207645 |
83 | MP0005334_abnormal_fat_pad | 1.04081892 |
84 | MP0004272_abnormal_basement_membrane | 1.01860705 |
85 | MP0004043_abnormal_pH_regulation | 1.01428956 |
86 | MP0009278_abnormal_bone_marrow | 1.00787848 |
87 | MP0010155_abnormal_intestine_physiology | 0.99711315 |
88 | MP0005166_decreased_susceptibility_to | 0.98922211 |
89 | MP0003868_abnormal_feces_composition | 0.97916108 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.96061895 |
91 | MP0002106_abnormal_muscle_physiology | 0.95440072 |
92 | MP0005266_abnormal_metabolism | 0.95168339 |
93 | MP0000733_abnormal_muscle_development | 0.94388554 |
94 | MP0002998_abnormal_bone_remodeling | 0.94011971 |
95 | MP0003011_delayed_dark_adaptation | 0.93427694 |
96 | MP0002332_abnormal_exercise_endurance | 0.90631357 |
97 | MP0000598_abnormal_liver_morphology | 0.90204455 |
98 | MP0001533_abnormal_skeleton_physiology | 0.88016910 |
99 | MP0001661_extended_life_span | 0.86865858 |
100 | MP0002060_abnormal_skin_morphology | 0.86089800 |
101 | MP0008438_abnormal_cutaneous_collagen | 0.85275796 |
102 | MP0001756_abnormal_urination | 0.84826141 |
103 | MP0008004_abnormal_stomach_pH | 0.84488593 |
104 | MP0004484_altered_response_of | 0.84481547 |
105 | MP0000230_abnormal_systemic_arterial | 0.84467868 |
106 | MP0003879_abnormal_hair_cell | 0.83572157 |
107 | MP0000678_abnormal_parathyroid_gland | 0.82167601 |
108 | MP0002896_abnormal_bone_mineralization | 0.82072572 |
109 | MP0009115_abnormal_fat_cell | 0.81057202 |
110 | MP0001545_abnormal_hematopoietic_system | 0.80059773 |
111 | MP0005397_hematopoietic_system_phenotyp | 0.80059773 |
112 | MP0009697_abnormal_copulation | 0.79359990 |
113 | * MP0000759_abnormal_skeletal_muscle | 0.79207974 |
114 | MP0005464_abnormal_platelet_physiology | 0.79153460 |
115 | MP0003183_abnormal_peptide_metabolism | 0.78483262 |
116 | MP0000604_amyloidosis | 0.77613919 |
117 | MP0000249_abnormal_blood_vessel | 0.77557044 |
118 | MP0005636_abnormal_mineral_homeostasis | 0.77307830 |
119 | MP0005376_homeostasis/metabolism_phenot | 0.76488188 |
120 | MP0005025_abnormal_response_to | 0.76334054 |
121 | MP0005501_abnormal_skin_physiology | 0.75771872 |
122 | * MP0009642_abnormal_blood_homeostasis | 0.75675702 |
123 | MP0005369_muscle_phenotype | 0.75218190 |
124 | MP0005448_abnormal_energy_balance | 0.74758184 |
125 | * MP0009763_increased_sensitivity_to | 0.74308166 |
126 | MP0002970_abnormal_white_adipose | 0.73049885 |
127 | * MP0004085_abnormal_heartbeat | 0.72966227 |
128 | MP0000343_altered_response_to | 0.68759033 |
129 | MP0009764_decreased_sensitivity_to | 0.67848930 |
130 | MP0000013_abnormal_adipose_tissue | 0.67418868 |
131 | MP0005165_increased_susceptibility_to | 0.66749035 |
132 | MP0005647_abnormal_sex_gland | 0.64159740 |
133 | MP0008469_abnormal_protein_level | 0.62987037 |
134 | MP0003690_abnormal_glial_cell | 0.61226368 |
135 | MP0003329_amyloid_beta_deposits | 0.59472155 |
136 | MP0003828_pulmonary_edema | 0.58920004 |
137 | MP0004147_increased_porphyrin_level | 0.58083589 |
138 | MP0002254_reproductive_system_inflammat | 0.57565150 |
139 | MP0003950_abnormal_plasma_membrane | 0.56390141 |
140 | MP0005275_abnormal_skin_tensile | 0.55283665 |
141 | MP0009384_cardiac_valve_regurgitation | 0.54459183 |
142 | MP0002127_abnormal_cardiovascular_syste | 0.54447703 |
143 | MP0008961_abnormal_basal_metabolism | 0.51890020 |
144 | MP0003953_abnormal_hormone_level | 0.50309635 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 5.10913845 |
2 | Hyperglycinuria (HP:0003108) | 4.78806780 |
3 | Hyperammonemia (HP:0001987) | 4.67151081 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.60095413 |
5 | Ketosis (HP:0001946) | 4.58967801 |
6 | Deep venous thrombosis (HP:0002625) | 4.58611295 |
7 | Intrahepatic cholestasis (HP:0001406) | 4.54243620 |
8 | Xanthomatosis (HP:0000991) | 4.53208217 |
9 | * Abnormality of fatty-acid metabolism (HP:0004359) | 4.45558931 |
10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34077053 |
11 | Abnormality of glycine metabolism (HP:0010895) | 4.34077053 |
12 | Ketoacidosis (HP:0001993) | 4.29225739 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.99898401 |
14 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.92350672 |
15 | * Myoglobinuria (HP:0002913) | 3.87057949 |
16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.86926668 |
17 | Hyperglycinemia (HP:0002154) | 3.86634712 |
18 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.81195854 |
19 | * Dicarboxylic aciduria (HP:0003215) | 3.81195854 |
20 | Hypoalphalipoproteinemia (HP:0003233) | 3.76587333 |
21 | Hypobetalipoproteinemia (HP:0003563) | 3.73419911 |
22 | Distal lower limb muscle weakness (HP:0009053) | 3.63482884 |
23 | Prolonged partial thromboplastin time (HP:0003645) | 3.61241701 |
24 | Hypolipoproteinemia (HP:0010981) | 3.56342266 |
25 | Sudden death (HP:0001699) | 3.48808802 |
26 | Generalized aminoaciduria (HP:0002909) | 3.37432533 |
27 | Complement deficiency (HP:0004431) | 3.34524360 |
28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32584519 |
29 | Cerebral edema (HP:0002181) | 3.28105062 |
30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.27242850 |
31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.26697096 |
32 | Distal lower limb amyotrophy (HP:0008944) | 3.24860792 |
33 | Type 1 muscle fiber predominance (HP:0003803) | 3.21902043 |
34 | Myopathic facies (HP:0002058) | 3.14742428 |
35 | Epidermoid cyst (HP:0200040) | 3.13072336 |
36 | Systemic lupus erythematosus (HP:0002725) | 3.12769812 |
37 | Ventricular tachycardia (HP:0004756) | 3.06446900 |
38 | * Rhabdomyolysis (HP:0003201) | 3.05349488 |
39 | Protrusio acetabuli (HP:0003179) | 3.04598165 |
40 | Metabolic acidosis (HP:0001942) | 3.03766139 |
41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02281392 |
42 | Exercise-induced muscle cramps (HP:0003710) | 2.93366516 |
43 | Right ventricular cardiomyopathy (HP:0011663) | 2.92484042 |
44 | Hemorrhage of the eye (HP:0011885) | 2.88943142 |
45 | Muscle fiber inclusion bodies (HP:0100299) | 2.87967240 |
46 | Increased muscle lipid content (HP:0009058) | 2.86943161 |
47 | Palpitations (HP:0001962) | 2.86776323 |
48 | Abnormality of serum amino acid levels (HP:0003112) | 2.85438059 |
49 | * Lethargy (HP:0001254) | 2.84926642 |
50 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.81804580 |
51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.79870194 |
52 | * Hepatic necrosis (HP:0002605) | 2.79490471 |
53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.78839102 |
54 | Vertebral compression fractures (HP:0002953) | 2.73406642 |
55 | Proximal tubulopathy (HP:0000114) | 2.72452650 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.69971208 |
57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69718890 |
58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.69335416 |
59 | Nemaline bodies (HP:0003798) | 2.68256502 |
60 | Abnormality of methionine metabolism (HP:0010901) | 2.63801962 |
61 | Calf muscle hypertrophy (HP:0008981) | 2.61855014 |
62 | Thin bony cortex (HP:0002753) | 2.61847615 |
63 | Hyporeflexia of lower limbs (HP:0002600) | 2.60561850 |
64 | Joint hemorrhage (HP:0005261) | 2.60486409 |
65 | Nausea (HP:0002018) | 2.58532804 |
66 | Dysostosis multiplex (HP:0000943) | 2.56450564 |
67 | Acute encephalopathy (HP:0006846) | 2.55290665 |
68 | Lipoatrophy (HP:0100578) | 2.55125166 |
69 | Mucopolysacchariduria (HP:0008155) | 2.53262595 |
70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53262595 |
71 | Muscle fiber splitting (HP:0003555) | 2.52937217 |
72 | Skin nodule (HP:0200036) | 2.52607381 |
73 | Renal cortical cysts (HP:0000803) | 2.51584454 |
74 | Cerebral aneurysm (HP:0004944) | 2.50038859 |
75 | Gout (HP:0001997) | 2.48695517 |
76 | Abnormality of purine metabolism (HP:0004352) | 2.45702043 |
77 | Hypercholesterolemia (HP:0003124) | 2.45549155 |
78 | * Vomiting (HP:0002013) | 2.44988893 |
79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44868405 |
80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44116808 |
81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44116808 |
82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44116808 |
83 | Fat malabsorption (HP:0002630) | 2.41908282 |
84 | Premature rupture of membranes (HP:0001788) | 2.40993664 |
85 | Abnormality of the intrinsic pathway (HP:0010989) | 2.39525879 |
86 | Dilated cardiomyopathy (HP:0001644) | 2.39505793 |
87 | Cervical subluxation (HP:0003308) | 2.38960733 |
88 | Hyperbilirubinemia (HP:0002904) | 2.38238933 |
89 | Cholelithiasis (HP:0001081) | 2.37888328 |
90 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.37681068 |
91 | EMG: myopathic abnormalities (HP:0003458) | 2.37365226 |
92 | Atrioventricular block (HP:0001678) | 2.35749814 |
93 | Delayed CNS myelination (HP:0002188) | 2.33643065 |
94 | Abnormality of complement system (HP:0005339) | 2.32727000 |
95 | Hypoglycemic seizures (HP:0002173) | 2.32422324 |
96 | Abnormal gallbladder morphology (HP:0012437) | 2.31277551 |
97 | Difficulty climbing stairs (HP:0003551) | 2.30871615 |
98 | Increased connective tissue (HP:0009025) | 2.29794615 |
99 | Bundle branch block (HP:0011710) | 2.26457431 |
100 | Achilles tendon contracture (HP:0001771) | 2.24828201 |
101 | Abnormality of proline metabolism (HP:0010907) | 2.24444536 |
102 | Hydroxyprolinuria (HP:0003080) | 2.24444536 |
103 | Abnormality of the Achilles tendon (HP:0005109) | 2.23189878 |
104 | Conjunctival hamartoma (HP:0100780) | 2.22471984 |
105 | Neck muscle weakness (HP:0000467) | 2.22306284 |
106 | Asymmetric septal hypertrophy (HP:0001670) | 2.22014680 |
107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21801550 |
108 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21801550 |
109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21801550 |
110 | Atrial fibrillation (HP:0005110) | 2.21261219 |
111 | Lactic acidosis (HP:0003128) | 2.20059377 |
112 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19818686 |
113 | Hyperglycemia (HP:0003074) | 2.15995535 |
114 | Flat acetabular roof (HP:0003180) | 2.15389048 |
115 | * Exercise-induced myalgia (HP:0003738) | 2.15254105 |
116 | Abnormality of glycolysis (HP:0004366) | 2.15211671 |
117 | Increased serum pyruvate (HP:0003542) | 2.15211671 |
118 | J-shaped sella turcica (HP:0002680) | 2.13106097 |
119 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11180319 |
120 | Increased purine levels (HP:0004368) | 2.10554337 |
121 | Hyperuricemia (HP:0002149) | 2.10554337 |
122 | Ragged-red muscle fibers (HP:0003200) | 2.10101975 |
123 | Late onset (HP:0003584) | 2.10008538 |
124 | Malnutrition (HP:0004395) | 2.08412263 |
125 | Glycosuria (HP:0003076) | 2.08388600 |
126 | Abnormality of urine glucose concentration (HP:0011016) | 2.08388600 |
127 | Upper limb amyotrophy (HP:0009129) | 2.07950844 |
128 | Distal upper limb amyotrophy (HP:0007149) | 2.07950844 |
129 | Broad face (HP:0000283) | 2.07582497 |
130 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06611871 |
131 | Syncope (HP:0001279) | 2.06597609 |
132 | Spinal rigidity (HP:0003306) | 2.06312518 |
133 | Heart block (HP:0012722) | 2.05709697 |
134 | Ulnar deviation of the wrist (HP:0003049) | 2.05201616 |
135 | Round ear (HP:0100830) | 2.04617732 |
136 | Glomerulonephritis (HP:0000099) | 2.04386692 |
137 | Bulbar palsy (HP:0001283) | 2.03509903 |
138 | Joint stiffness (HP:0001387) | 2.02787384 |
139 | Difficulty running (HP:0009046) | 2.02403491 |
140 | Lower limb amyotrophy (HP:0007210) | 2.02396022 |
141 | Abnormality of the calf musculature (HP:0001430) | 2.02006045 |
142 | Myocardial infarction (HP:0001658) | 2.01459474 |
143 | Nuclear cataract (HP:0100018) | 2.01059934 |
144 | Primary atrial arrhythmia (HP:0001692) | 1.99388292 |
145 | Stridor (HP:0010307) | 1.98036525 |
146 | Methylmalonic aciduria (HP:0012120) | 1.97820272 |
147 | Axonal loss (HP:0003447) | 1.96139784 |
148 | Hypertriglyceridemia (HP:0002155) | 1.96000555 |
149 | Foot dorsiflexor weakness (HP:0009027) | 1.95937635 |
150 | Aneurysm (HP:0002617) | 1.94414988 |
151 | Abnormal atrioventricular conduction (HP:0005150) | 1.94079972 |
152 | Hepatocellular carcinoma (HP:0001402) | 1.93958806 |
153 | Ulnar bowing (HP:0003031) | 1.91515198 |
154 | Eczematoid dermatitis (HP:0000976) | 1.86031988 |
155 | Hyperacusis (HP:0010780) | 1.85341402 |
156 | Abnormality of the foot musculature (HP:0001436) | 1.82332462 |
157 | Fragile skin (HP:0001030) | 1.78941007 |
158 | Scapular winging (HP:0003691) | 1.78046282 |
159 | Interstitial pulmonary disease (HP:0006530) | 1.77955014 |
160 | Back pain (HP:0003418) | 1.77310585 |
161 | Amyloidosis (HP:0011034) | 1.74808574 |
162 | Neurofibrillary tangles (HP:0002185) | 1.74620044 |
163 | Colitis (HP:0002583) | 1.71622632 |
164 | Atrophic scars (HP:0001075) | 1.70276418 |
165 | Ventricular arrhythmia (HP:0004308) | 1.68702209 |
166 | Biconcave vertebral bodies (HP:0004586) | 1.67282188 |
167 | Reticulocytosis (HP:0001923) | 1.66155550 |
168 | EMG: neuropathic changes (HP:0003445) | 1.65576401 |
169 | Cerebral inclusion bodies (HP:0100314) | 1.64311146 |
170 | Polycythemia (HP:0001901) | 1.62700090 |
171 | Nephritis (HP:0000123) | 1.62339700 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.28067619 |
2 | TRIB3 | 3.68254789 |
3 | TTN | 3.57963093 |
4 | PDK4 | 3.56470880 |
5 | PDK3 | 3.56470880 |
6 | PKN2 | 3.04911203 |
7 | SIK1 | 2.86174857 |
8 | OBSCN | 2.53319256 |
9 | LMTK2 | 2.52222100 |
10 | PRPF4B | 2.45931224 |
11 | ERN1 | 2.44621169 |
12 | FGFR4 | 2.40695145 |
13 | PHKG2 | 2.20892466 |
14 | PHKG1 | 2.20892466 |
15 | PDK2 | 2.20073670 |
16 | MYLK | 2.16360928 |
17 | INSRR | 2.14778056 |
18 | TIE1 | 1.89157554 |
19 | IRAK3 | 1.88286757 |
20 | EEF2K | 1.81673055 |
21 | PINK1 | 1.80853850 |
22 | SMG1 | 1.78512126 |
23 | EPHA2 | 1.68793714 |
24 | NEK1 | 1.60188330 |
25 | CDC42BPA | 1.58144252 |
26 | FLT3 | 1.55939098 |
27 | PIK3CA | 1.50384578 |
28 | TESK1 | 1.43643107 |
29 | PRKAA2 | 1.36179721 |
30 | CAMK1D | 1.34094372 |
31 | MAP3K13 | 1.32153957 |
32 | ZAP70 | 1.29954303 |
33 | MAP3K6 | 1.28370955 |
34 | MAP2K3 | 1.21162447 |
35 | WNK4 | 1.20441495 |
36 | NEK9 | 1.15984343 |
37 | MAP3K7 | 1.15776988 |
38 | PIK3CG | 1.15407895 |
39 | DDR2 | 1.13387844 |
40 | RIPK1 | 1.13039261 |
41 | STK38L | 1.12363559 |
42 | MST1R | 1.11723154 |
43 | TAOK2 | 1.11506099 |
44 | MAP3K1 | 1.07895011 |
45 | NME2 | 1.07225017 |
46 | EPHB1 | 1.03422908 |
47 | KDR | 1.03388439 |
48 | MAP3K3 | 1.01928790 |
49 | PRKAA1 | 0.99162886 |
50 | MAPK11 | 0.98936421 |
51 | PTK6 | 0.98850049 |
52 | NTRK1 | 0.96909156 |
53 | PTK2 | 0.96466759 |
54 | LATS1 | 0.96450386 |
55 | PRKD2 | 0.95265731 |
56 | TGFBR2 | 0.93287057 |
57 | CDK12 | 0.92794003 |
58 | MAPK12 | 0.91473619 |
59 | PAK3 | 0.91082418 |
60 | DMPK | 0.90090295 |
61 | PIM2 | 0.89954416 |
62 | TESK2 | 0.89034326 |
63 | MAP2K4 | 0.88028407 |
64 | STK24 | 0.86634164 |
65 | PRKD1 | 0.84237300 |
66 | ARAF | 0.83495093 |
67 | KSR2 | 0.83173509 |
68 | ERBB4 | 0.82056768 |
69 | SCYL2 | 0.80427169 |
70 | MARK2 | 0.79307064 |
71 | RPS6KA2 | 0.77672788 |
72 | PDGFRA | 0.77208081 |
73 | PDPK1 | 0.76437660 |
74 | PAK4 | 0.75621760 |
75 | BLK | 0.73599390 |
76 | JAK3 | 0.73275260 |
77 | JAK1 | 0.71971886 |
78 | TYK2 | 0.71898902 |
79 | MAP3K14 | 0.70905240 |
80 | CAMK1G | 0.70859675 |
81 | TAOK1 | 0.70630998 |
82 | MAP4K1 | 0.69969363 |
83 | TAOK3 | 0.68339166 |
84 | PRKACG | 0.66943964 |
85 | JAK2 | 0.65514868 |
86 | LATS2 | 0.64745036 |
87 | MOS | 0.64420084 |
88 | FRK | 0.62983951 |
89 | MAPK15 | 0.62119910 |
90 | RPS6KC1 | 0.61392612 |
91 | RPS6KL1 | 0.61392612 |
92 | TBK1 | 0.59488173 |
93 | GRK7 | 0.59381881 |
94 | CAMK2D | 0.59300735 |
95 | DYRK1B | 0.59017674 |
96 | ABL2 | 0.58944567 |
97 | BMX | 0.58572200 |
98 | EPHA3 | 0.56946529 |
99 | RIPK4 | 0.55774491 |
100 | MAP2K2 | 0.55284363 |
101 | FGFR2 | 0.54810641 |
102 | PDK1 | 0.54657242 |
103 | ILK | 0.53595318 |
104 | CAMK2G | 0.53488353 |
105 | MAP3K5 | 0.52868272 |
106 | MAP2K1 | 0.52692293 |
107 | PRKD3 | 0.52262383 |
108 | MAPKAPK3 | 0.50927170 |
109 | MUSK | 0.50198832 |
110 | MET | 0.49993417 |
111 | SGK3 | 0.48122957 |
112 | PDGFRB | 0.45867857 |
113 | FGFR3 | 0.45499027 |
114 | PKN1 | 0.44837124 |
115 | ROCK1 | 0.44691290 |
116 | MAP3K11 | 0.43273388 |
117 | RET | 0.40864549 |
118 | MAPK4 | 0.40661175 |
119 | HIPK2 | 0.40651054 |
120 | RPS6KA6 | 0.40646046 |
121 | ICK | 0.40200984 |
122 | PRKCH | 0.38770539 |
123 | GSK3A | 0.38531464 |
124 | CAMK4 | 0.38107160 |
125 | LRRK2 | 0.35948532 |
126 | TRPM7 | 0.34914249 |
127 | STK39 | 0.34763964 |
128 | MAP2K6 | 0.34699149 |
129 | MTOR | 0.34676690 |
130 | DAPK3 | 0.33673891 |
131 | FER | 0.33265692 |
132 | PRKACB | 0.31150942 |
133 | PRKACA | 0.29803482 |
134 | STK38 | 0.29654387 |
135 | MAP3K10 | 0.28464689 |
136 | MAPK7 | 0.25541026 |
137 | PRKCZ | 0.25409222 |
138 | SGK494 | 0.24401173 |
139 | SGK223 | 0.24401173 |
140 | STK4 | 0.24005686 |
141 | IGF1R | 0.23312496 |
142 | PRKG2 | 0.22813256 |
143 | CDK6 | 0.21398911 |
144 | PRKCQ | 0.21199594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.44943033 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.44146429 |
3 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.43363328 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.33570491 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.30121289 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21419343 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.12697809 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.09350586 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.93191550 |
10 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.68646190 |
11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.61794279 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48221098 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.46422693 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42179614 |
15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36673790 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33954048 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.33566012 |
18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22033002 |
19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.10991199 |
20 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07748966 |
21 | Peroxisome_Homo sapiens_hsa04146 | 2.02777024 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.93147337 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87174991 |
24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86960085 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84295804 |
26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.75662648 |
27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65466751 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49353357 |
29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37852952 |
30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35599730 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35113550 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34989265 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33628515 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30216371 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29147018 |
36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28747337 |
37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27949392 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19895225 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17805929 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.17604485 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16932686 |
42 | Lysosome_Homo sapiens_hsa04142 | 1.16725700 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15819594 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13079594 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10865122 |
46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08713239 |
47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08601924 |
48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08578797 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05466740 |
50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01545208 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99838475 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99740890 |
53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98423737 |
54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95220483 |
55 | Lysine degradation_Homo sapiens_hsa00310 | 0.94642766 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93882768 |
57 | ABC transporters_Homo sapiens_hsa02010 | 0.91817974 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91815423 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91389043 |
60 | Pertussis_Homo sapiens_hsa05133 | 0.89045516 |
61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81337002 |
62 | Focal adhesion_Homo sapiens_hsa04510 | 0.81160575 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79128447 |
64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78979286 |
65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.78830820 |
66 | Bladder cancer_Homo sapiens_hsa05219 | 0.78115889 |
67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77683190 |
68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77662604 |
69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77128276 |
70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76886707 |
71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74142214 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.73234013 |
73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72978282 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72334388 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71118441 |
76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70965837 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70788727 |
78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68126118 |
79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66804640 |
80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65352769 |
81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64900044 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.63144830 |
83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63089606 |
84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62916207 |
85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59541410 |
86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59345300 |
87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57630419 |
88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57559500 |
89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57445284 |
90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56266903 |
91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55407036 |
92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54128235 |
93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53272963 |
94 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51066664 |
95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50251870 |
96 | Mineral absorption_Homo sapiens_hsa04978 | 0.49054915 |
97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48744463 |
98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48154751 |
99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48094859 |
100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47747453 |
101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47730331 |
102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47638450 |
103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46926999 |
104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46525256 |
105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46461476 |
106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46010255 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45623561 |
108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44910976 |
109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44359015 |
110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44072283 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43903483 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43467545 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42335200 |
114 | Salmonella infection_Homo sapiens_hsa05132 | 0.41175645 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39688101 |
116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39413187 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29728776 |
118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26108619 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22113639 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20937655 |
121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18253965 |
122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15329319 |
123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11090415 |
124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09383872 |
125 | Prion diseases_Homo sapiens_hsa05020 | 0.07361078 |
126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06666335 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04829239 |
128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.03769543 |
129 | Amoebiasis_Homo sapiens_hsa05146 | -0.1256562 |
130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1231755 |
131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.1199899 |
132 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1053562 |
133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0942034 |
134 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0641190 |
135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0598074 |
136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0293289 |